Finally, OS-based univariate and multivariate analyses of the pathological features of clinical patients revealed that TOP2A was an independent risk factor influencing the prognosis of NSCLC (Additional File 2, Table S2). The gene discussed is TOP2A; the disease is non-small cell lung carcinoma.